Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects clinical trial (NCT00125346). Contact the study team or your healthcare provider for specific answers.

Question 2

How does TIP compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects clinical trial (NCT00125346). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while using TIP?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects clinical trial (NCT00125346). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects clinical trial (NCT00125346). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects clinical trial (NCT00125346). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects clinical trial (NCT00125346). Contact the study team or your healthcare provider for specific answers.

What this study is about